IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
16.50
-0.55 (-3.23%)
Mar 31, 2025, 10:53 AM EDT - Market open
IDEAYA Biosciences Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for IDEAYA Biosciences stock have an average target of 53.58, with a low estimate of 27 and a high estimate of 68. The average target predicts an increase of 224.73% from the current stock price of 16.50.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 14, 2025.
Analyst Ratings
The average analyst rating for IDEAYA Biosciences stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 6 | 5 | 5 | 5 | 5 | 5 |
Buy | 5 | 6 | 7 | 7 | 7 | 7 |
Hold | 0 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 12 | 13 | 13 | 13 | 13 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stephens & Co. | Stephens & Co. | Buy Reiterates $50 | Buy | Reiterates | $50 | +203.03% | Feb 14, 2025 |
RBC Capital | RBC Capital | Buy Reiterates $61 | Buy | Reiterates | $61 | +269.70% | Jan 15, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jan 13, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Dec 17, 2024 |
Wedbush | Wedbush | Buy Reiterates $52 | Buy | Reiterates | $52 | +215.15% | Dec 17, 2024 |
Financial Forecast
Revenue This Year
13.24M
from 7.00M
Increased by 89.14%
Revenue Next Year
51.81M
from 13.24M
Increased by 291.34%
EPS This Year
-2.93
from -3.36
EPS Next Year
-2.93
from -2.93
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 45.2M | 183.2M | 225.2M | ||
Avg | 13.2M | 51.8M | 171.1M | ||
Low | n/a | n/a | 131.1M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 545.0% | 1,283.6% | 334.7% | ||
Avg | 89.1% | 291.3% | 230.2% | ||
Low | - | - | 153.0% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -2.23 | -1.96 | -1.26 | ||
Avg | -2.93 | -2.93 | -2.57 | ||
Low | -3.57 | -3.98 | -3.58 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.